Equity Research

technology m slide top

RESEARCH APPROACH

WestPark Capital’s newly formed and developing equity research team is focused on high-growth, disruptive technology themes. This experienced team of analysts is a new voice in equity research that is changing the style, shape, and scope of research communications through its modern delivery methods, dedication to collaboration, and focus on where technology trends are evolving.

Instead of general coverage of every stock in a sector, WestPark’s approach provides coverage only on those companies that are the beneficiaries of our defined disruptive investment themes, which are supported by proprietary, bottoms-up research.

Currently, the team provides coverage of artificial intelligence, quantum computing, the cloud and data center, and the fiber broadband demand cycle, with plans to expand into rapidly developing sectors such as financial technology and payments.

For these reasons, WestPark’s expanding client base gains valuable insights and unique approaches to investing that are concise and actionable. Our dedicated coverage teams make sure our clients are informed in a timely and thoughtful way.

Client Portal

Research Team

Casey Ryan

Casey Ryan

Director of Research

Casey Ryan works in the Research Department at West Park Capital. Casey is focused on building a leading research coverage universe across multiple technology verticals and implement best in class processes for the research product and distribution at WestPark Capital. Casey previously served as a Managing Director at Berg Capital Markets leading fundraising for private companies primarily in the healthcare software sector from 2019-2022. From 20212-2019, Casey was the Director of Research at Lyon Street Capital, a $300 million hedge fund, leading all research initiatives and processes. From 2010 to 2012 Casey was a Senior Vice President at GE Capital focusing on lending to corporate clients on the U.S. West Coast. Casey founded the data research company Diamond Tip Research which launched multiple products into the financial services arena targeted primarily at institutional asset managers. Casey holds a B.S. from Drexel University and an MBA from Vanderbilt University.

no picture

Ed Arce

Senior Research Analyst, Biotechnology

Ed Arce joined WestPark Capital as a Managing Director to build a leading healthcare research platform. Mr. Arce covers emerging and small-to-midcap (SMID) biotechnology companies, focused on several therapeutic areas including hepatology; cardiovascular, renal & metabolism (CRM); inflammation & immunology (I&I); gastroenterology; and rare diseases. Mr. Arce brings nearly 20 years of experience with prior appointments at H.C. Wainwright, Roth Capital Partners, MLV & Co., Wedbush Securities and UBS Securities. In 2017, Mr. Arce was awarded the No. 1 Stock Picker in Biotechnology in the United States by the Thomson Reuters Analyst Awards.

Mr. Arce holds a B.S. in Civil Engineering and an MBA from Florida International University, an M.S. in Finance from Boston College, and an Executive Education Certificate by completing the Chief Financial Officer (CFO) Program from Columbia University. Mr. Arce holds the Series 7, 63, 86, and 87 registrations.

Research Team

Casey Ryan

Casey Ryan

Director of Research

Casey Ryan works in the Research Department at West Park Capital. Casey is focused on building a leading research coverage universe across multiple technology verticals and implement best in class processes for the research product and distribution at WestPark Capital. Casey previously served as a Managing Director at Berg Capital Markets leading fundraising for private companies primarily in the healthcare software sector from 2019-2022. From 20212-2019, Casey was the Director of Research at Lyon Street Capital, a $300 million hedge fund, leading all research initiatives and processes. From 2010 to 2012 Casey was a Senior Vice President at GE Capital focusing on lending to corporate clients on the U.S. West Coast. Casey founded the data research company Diamond Tip Research which launched multiple products into the financial services arena targeted primarily at institutional asset managers. Casey holds a B.S. from Drexel University and an MBA from Vanderbilt University.

no picture

Ed Arce

Senior Research Analyst, Biotechnology

Ed Arce joined WestPark Capital as a Managing Director to build a leading healthcare research platform. Mr. Arce covers emerging and small-to-midcap (SMID) biotechnology companies, focused on several therapeutic areas including hepatology; cardiovascular, renal & metabolism (CRM); inflammation & immunology (I&I); gastroenterology; and rare diseases. Mr. Arce brings nearly 20 years of experience with prior appointments at H.C. Wainwright, Roth Capital Partners, MLV & Co., Wedbush Securities and UBS Securities. In 2017, Mr. Arce was awarded the No. 1 Stock Picker in Biotechnology in the United States by the Thomson Reuters Analyst Awards.

Mr. Arce holds a B.S. in Civil Engineering and an MBA from Florida International University, an M.S. in Finance from Boston College, and an Executive Education Certificate by completing the Chief Financial Officer (CFO) Program from Columbia University. Mr. Arce holds the Series 7, 63, 86, and 87 registrations.